Search - tctmd.com

Displaying 61 - 80 of 2580

Sort: Relevancy | Date

Presentation TCT 2016

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben

November 01, 2016

Presentation TCT 2016

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Ted Feldman

November 01, 2016

Presentation TCT 2016

Portico: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Raj Makkar

November 01, 2016

Presentation TCT 2016

FFR in the setting of CABG and AS/AVR/TAVR

Presenter: Bernard De Bruyne, Allen Jeremias, Emanuele Barbato

November 01, 2016

Presentation TCT 2016

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Jeffrey J. Popma

November 01, 2016

Presentation TCT 2016

Sapien 3 and ULTRA: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., John G. Webb

November 01, 2016

Presentation TCT 2016

Future TAVR Devices and Adjunctive Therapies

Presenter: Blase A. Carabello, George D. Dangas

November 01, 2016

Presentation TCT 2016

TAVR: Current Status of Devices and Indications

Presenter: Blase A. Carabello, George D. Dangas, Vinod H. Thourani

November 01, 2016

Presentation TCT 2016

The Case for TAVR

Presenter: Michael A. Borger, Vinod H. Thourani, Brian K. Whisenant

November 01, 2016

Presentation TCT 2016

Fusion Imaging for TAVR: Is There Added Utility?

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Jeremy J Thaden

November 01, 2016

Presentation TCT 2016

Use of Intracardiac Echocardiography During TAVR

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Thomas Bartel

November 01, 2016

Presentation TCT 2016

Planning and Performing TAVR in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Anuj Gupta

November 01, 2016

Presentation TCT 2016

Post-TAVR Valve Thickening: Current Data and Open Questions

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Hasan Jilaihawi

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto

November 01, 2016

Presentation TCT 2016

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Rebecca T. Hahn

November 01, 2016

Presentation TCT 2016

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen

November 01, 2016

Presentation TCT 2016

Comprehensive CT Algorithm Before TAVR

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, João L Cavalcante

November 01, 2016

Presentation TCT 2016

Debate: Imaging For TAVR- The Case for TTE and the Minimalist Approach!

Presenter: Patrizio Lancellotti, Sunil V. Mankad, Stephen H. Little

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

News Conference News TCT 2016

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Todd Neale

November 01, 2016

Advertisement

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Lotus and EDGE: Design Features, Special Attributes, and Clinical Trial Program

Portico: Design Features, Special Attributes, and Clinical Trial Program

FFR in the setting of CABG and AS/AVR/TAVR

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Sapien 3 and ULTRA: Design Features, Special Attributes, and Clinical Trial Program

Future TAVR Devices and Adjunctive Therapies

TAVR: Current Status of Devices and Indications

The Case for TAVR

Fusion Imaging for TAVR: Is There Added Utility?

Use of Intracardiac Echocardiography During TAVR

Planning and Performing TAVR in the Patient With CKD

Post-TAVR Valve Thickening: Current Data and Open Questions

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients!

Debate: Imaging For TAVR- The Case for TEE and MAC/GA!

Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy!

Comprehensive CT Algorithm Before TAVR

Debate: Imaging For TAVR- The Case for TTE and the Minimalist Approach!

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content